Related Articles
Association of KRAS, NRAS, BRAF and PIK3CA gene mutations with clinicopathological features, prognosis and ring finger protein 215 expression in patients with colorectal cancer
KRAS, BRAF and PIK3CA mutations in human colorectal cancer: Relationship with metastatic colorectal cancer
EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab
Identification of KRAS and PIK3CA but not BRAF mutations in patients with gastric cancer
KRAS mutation in patients with metastatic colorectal cancer does not preclude benefit from oxaliplatin‑ or irinotecan‑based treatment